AbCellera Acquires TetraGenetics, Enhancing Capabilities to Generate Antibodies Against High-Value Targets

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 8/24/2026

1. NVDA
2. JMKE
3. BABA
4. REF
5. SPY
6. USO
7. TSLA
8. CAPR
9. GOOGL
10. PM

Go back to AbCellera Acquires TetraGenetics, Enhancing Capabilities to Generate Antibodies Against High-Value Targets

AbCellera (ABCL) Gains on Multi-Year Research Deal with Moderna (MRNA)

September 15, 2021 9:28 AM EDT

AbCellera (NASDAQ: ABCL) gains 11% in pre-open trade entered into a multi-year, multi-target research collaboration and license agreement with Moderna (NASDAQ: MRNA) to leverage AbCelleras AI-powered technology to search and analyze natural immune responses to identify therapeutic antibodies against up to six targets selected by Moderna.

... More